These organizations base their guidance on scientific evidence, not commercial interests
It may also mitigate the cognitive side effects of chemotherapy, particularly in pediatric oncology ( 12, 13 )
The FDAs decision was supported by the Phase III SUNLIGHT trial, where the LonsurfAvastin combination led to a median overall survival of 10.8 months versus 7.5 months on Lonsurf monotherapy, for a 39% reduction in risk of death
Doctors told her that tissue around the site of the jabs was dying due to the botched procedure, she claimed
Research Context Referenced by ProHealth BPC-157 has generated significant scientific interest, and ProHealth references a growing body of preclinical research in its product materials
This article stays tightly focused on the weight-loss question: what BPC-157 is, what evidence exists, what could plausibly influence body composition indirectly, why some people report the opposite outcome, and the safety/regulatory issues you should understand before taking claims at face value